Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis

Figure 3

OS of the 95 gastric cancer patients with PC who underwent conversion surgery, CRS + HIPEC, systemic chemotherapy, and palliative therapy. NIPS: neoadjuvant intraperitoneal and systemic chemotherapy; CRS + HIPEC: cytoreductive surgery + hyperthermic intraperitoneal chemotherapy; C/T: chemotherapy; MST: median survival time (months).